Aurobindo Pharma Ltd — Acyclovir Exporter Profile
Indian Pharmaceutical Exporter · #3 for Acyclovir · $2.0M export value · DGFT Verified
Aurobindo Pharma Ltd is the #3 Indian exporter of Acyclovir with $2.0M in export value and 41 verified shipments. Aurobindo Pharma Ltd holds a 1.6% market share in Acyclovir exports across 2 countries.
Aurobindo Pharma Ltd — Acyclovir Export Profile: Buyers & Destinations
Where Does Aurobindo Pharma Ltd Export Acyclovir?
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $2.0M | 40 | 90.8% |
| CANADA | $202.0K | 5 | 9.2% |
Aurobindo Pharma Ltd exports Acyclovir to 2 countries. The largest destination is UNITED STATES accounting for 90.8% of Aurobindo Pharma Ltd's Acyclovir shipments. These destinations reflect Aurobindo Pharma Ltd's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Acyclovir from Aurobindo Pharma Ltd?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| SIVEM PHARMACEUTICALS | UNITED STATES | $1.6M | 31 |
| NORTHSTAR HEALTHCARE | UNITED STATES | $287.9K | 6 |
| NORTHSTAR HEALTHCARE SIVEM PHARMACEUTICALS | UNITED STATES | $150.0K | 3 |
| AURO PHARMA INC | CANADA | $114.5K | 3 |
| AURO PHARMA INC, | CANADA | $87.5K | 2 |
Aurobindo Pharma Ltd supplies Acyclovir to 5 buyers globally. The largest buyer is SIVEM PHARMACEUTICALS (UNITED STATES), followed by NORTHSTAR HEALTHCARE (UNITED STATES) and NORTHSTAR HEALTHCARE SIVEM PHARMACEUTICALS (UNITED STATES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Acyclovir Export Value and How Much Does Aurobindo Pharma Ltd Contribute?
India exported $36.5M worth of Acyclovir through 5,956 shipments from 358 suppliers to 152 countries, serving 879 buyers globally. Aurobindo Pharma Ltd contributes $2.0M to this total, accounting for 1.6% of India's Acyclovir exports. Aurobindo Pharma Ltd ships Acyclovir to 2 countries through 5 buyers.
What Is the Average Shipment Value for Aurobindo Pharma Ltd's Acyclovir Exports?
Aurobindo Pharma Ltd's average Acyclovir shipment value is $50.0K per consignment, based on 41 shipments totaling $2.0M. The largest destination is UNITED STATES (90.8% of Aurobindo Pharma Ltd's Acyclovir exports).
How Does Aurobindo Pharma Ltd Compare to Other Indian Acyclovir Exporters?
Aurobindo Pharma Ltd ranks #3 among 358 Indian Acyclovir exporters with a 1.6% market share. The top 3 exporters are HETERO LABS LIMITED ($16.4M), ZYDUS LIFESCIENCES LIMITED ($4.3M), MYLAN LABORATORIES LIMITED ($4.2M). Aurobindo Pharma Ltd processed 41 shipments to 2 destination countries.
What Acyclovir Formulations Does Aurobindo Pharma Ltd Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| VALACICLOVIR TABLETS 500MG (VALACYCLOVIR | $1.6M | 31 |
| VALACICLOVIR TABLETS 500 MG (VALACYCLOVIR TABLETS 500 MG) 100'S | $237.9K | 5 |
| VALACICLOVIR TABLETS 500MG ValacyclovirTablets 500 mg 100'S | $150.0K | 3 |
| VALACICLOVIR TABLETS 500 MG HCL AURO-VALACYCLOVIR 500 100'S 12216 PACK | $50.0K | 1 |
| VALACICLOVIR TABLETS 500MG (VALACYCLOVIRTABLETS 500 MG) 100'S | $50.0K | 1 |
| VALACICLOVIR TABLETS 500 MG(AURO-VALACYCLOVIR 500)100'S(QTY:12240PAK) | $50.0K | 1 |
| VALACICLOVIR TABLETS 500 MG (AURO-VALACYCLOVIR 500) 100'S (VALACICLOVIR HCL TABLETS 500MG) (24576 PACK) | $50.0K | 1 |
| VALACICLOVIR TABLETS 1000 MG (1G) (AURO-VALACYCLOVIR 1000) 100'S (QTY: 1296 PAK) | $37.5K | 1 |
| VALACICLOVIR TABLETS 1000 MG (1G) (AURO-VALACYCLOVIR 1000) 21'S (2475 PACK) | $14.5K | 1 |
Aurobindo Pharma Ltd exports 9 distinct Acyclovir formulations including tablets, capsules, syrups, and combination drugs. The top formulation is VALACICLOVIR TABLETS 500MG (VALACYCLOVIR with 31 shipments worth $1.6M.
Regulatory Requirements: Exporting Acyclovir to Key Markets
What Aurobindo Pharma Ltd must comply with to export Acyclovir to its top destination countries
United States — FDA
Approval Process
ANDA (Abbreviated New Drug Application) for generics. Indian manufacturing site must pass FDA pre-approval inspection. Drug Master File (DMF) required for APIs.
Timeline: 10–18 months for ANDA approval
GMP & Export Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA
Drug Listing with FDA; Export Certificate from CDSCO India; Import Alert screening via FDA PREDICT system
Note: Subject to FDA Import Alerts. Open Form 483 observations can block all exports from a facility.
Canada — HC
Approval Process
ANDS (Abbreviated New Drug Submission) referencing Canadian Reference Product. Comparative bioavailability study required.
Timeline: 12–18 months
GMP & Export Requirements
Health Canada GMP (GUI-0001); Drug Establishment Licence (DEL) inspection
Drug Identification Number (DIN) for each product; Certificate of Pharmaceutical Product from CDSCO
Note: Subject to Good Import Practices and annual C.01.014.6 review.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Aurobindo Pharma Ltd Compare to Nearest Acyclovir Exporters?
Exporters ranked immediately above and below #3 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | MYLAN LABORATORIES LIMITED | $4.2M | 83 | 3 | $50.0K |
| 5 | EUGIA PHARMA SPECIALITIES LIMITED | $2.9M | 58 | 2 | $50.0K |
| 3 | AUROBINDO PHARMA LTD ★ | $2.0M | 41 | 2 | $50.0K |
| 7 | CIPLA LIMITED | $1.9M | 68 | 6 | $28.0K |
| 8 | V S INTERNATIONAL PRIVATE LIMITED | $1.3M | 37 | 1 | $35.6K |
Aurobindo Pharma Ltd ranks #3 among 358 Indian Acyclovir exporters. Average shipment value of $50.0K compared to the market average of $101.9K. The closest competitors by value are MYLAN LABORATORIES LIMITED and EUGIA PHARMA SPECIALITIES LIMITED.
Which Indian Ports Ship Acyclovir Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 1,255 | 21.1% |
| DELHI AIR CARGO ACC (INDEL4) | 938 | 15.7% |
| SAHAR AIR | 878 | 14.7% |
| DELHI AIR | 615 | 10.3% |
| Bombay Air | 249 | 4.2% |
| NHAVA SHEVA SEA (INNSA1) | 195 | 3.3% |
| Delhi Air | 188 | 3.2% |
| Bombay Air Cargo | 113 | 1.9% |
Market Intelligence
Latest developments and market context
Detailed market intelligence for Acyclovir — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Acyclovir shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Aurobindo Pharma Ltd matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 45 individual customs records matching Aurobindo Pharma Ltd exporting Acyclovir, covering 9 formulations to 2 countries via 5 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 152+ countries, 879+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Acyclovir Export Data from Aurobindo Pharma Ltd
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Aurobindo Pharma Ltd's Acyclovir exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Aurobindo Pharma Ltd
Company Profile
0 products · $0 total trade · 0 categories
Acyclovir Stats
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Aurobindo Pharma Ltd.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Acyclovir. For current shipment-level data, contact TransData Nexus.